ストックスクリーナーアプリを入手
2.91
1.69%
-0.05
前日終値:
$2.96
開ける：
$2.98
24時間の取引高:
1.76M
Relative Volume:
2.34
時価総額：
$183.99M
収益：
$4.39M
当期純損益:
$-22.40M
株価収益率:
-5.7081
EPS:
-0.5098
ネットキャッシュフロー:
$-22.79M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+8.99%
6か月 パフォーマンス:
+155.26%
1年 パフォーマンス:
+735.73%
1日の値動き範囲:
$2.81
$3.04
1週間の範囲:
$2.68
$3.155
52週間の値動き範囲:
$0.331
$3.54
Equillium Inc Stock (EQ) Company Profile
Compare EQ vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
2.91 | 183.99M | 4.39M | -22.40M | -22.79M | -0.5098 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-23 | 開始されました | Oppenheimer | Outperform |
| 2026-04-16 | 開始されました | B. Riley Securities | Buy |
| 2026-04-14 | 開始されました | Raymond James | Strong Buy |
| 2026-04-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2026-03-13 | 開始されました | Roth Capital | Buy |
| 2026-02-25 | 開始されました | Stifel | Buy |
| 2025-03-28 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | 再開されました | Stifel | Buy |
| 2021-09-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-14 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-10 | 再開されました | Stifel | Buy |
| 2019-02-22 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Equillium Inc (EQ) 最新ニュース
ETFs Investing in Equillium, Inc. Stocks - TradingView
EQ Q1 2026 Earnings: EPS Misses Estimates as Company Continues Development-Stage OperationsEarnings Risk Report - dars.gov.et
Equillium(EQ) Stock Options Chain | Quotes & News - Moomoo
EQ News | EQUILLIUM INC (NASDAQ:EQ) - ChartMill
Equillium (EQ) Gets a Buy from Oppenheimer - The Globe and Mail
Equillium (EQ) Cantor Global Healthcare Conference 2025 Summary - Quartr
Roth MKM Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Equillium stock rating reaffirmed by Oppenheimer on rival drug data - Investing.com Canada
Equillium, Inc.(NasdaqCM: EQ) added to Russell 3000E Growth Benchmark - marketscreener.com
Equillium, Inc.(NasdaqCM: EQ) added to Russell Microcap Index - marketscreener.com
Equillium, Inc.(NasdaqCM: EQ) added to Russell 3000E Index - marketscreener.com
Equillium, Inc.(NasdaqCM: EQ) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Equillium Inc. (EQ) Q1 2026 Earnings: EPS Misses Estimates, Stock Gains 3.39% Amid Strategic Progress - dars.gov.et
Equillium Inc. (EQ) Rallies 3.39% as Stock Approaches Key Resistance LevelProfit Surge Picks - dars.gov.et
Price to book forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Enterprise value to EBIT forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Price to sales forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Price to earnings forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Equillium, Inc. Actuals & Estimates (NASDAQ:EQ) - TradingView
EQ Forecast — Price Target — Prediction for 2027 - TradingView
EQ Q1 2026 Earnings: EPS Miss Amid Pipeline Progress; Stock Rises 3%Special Dividend Alert - dars.gov.et
Equillium Inc (EQ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
EQ Q1 2026 Earnings: EPS Miss Reflects Higher R&D Spend; Stock Gains SlightlyROE Trend Analysis - dars.gov.et
EQUILLIUM INC (EQ) Stock Chart - ChartMill
23% Of This Equillium Insider's Holdings Were Sold - simplywall.st
Equillium Inc (EQ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Equillium Inc (EQ) Institutional Confidence - TradingKey
Equillium Inc (EQ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Equillium Inc (EQ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Equillium Inc (EQ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Equillium Inc (EQ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Equillium Inc (EQ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Equillium Inc (EQ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Equillium Inc. (EQ) Jumps 8.7%: Volume Surge and Key Resistance AheadNarrow Range Breakout - dars.gov.et
Equillium Inc. (EQ) Holds Steady at $2.81 – Key Support and Resistance Levels in FocusSystematic Flow - newsline.com
Equillium’s Lead Asset EQ504 Sees Growing Analyst Confidence Amid Pipeline ProgressDividend Cut Risk - newsline.com
Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504 - Insider Monkey
EQ Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesRevenue Miss Report - newsline.com
Equillium COO Christine Zedelmayer sells $42,736 in stock - Investing.com UK
Insider Sell: Stephen Connelly Sells 230,975 Shares of Equillium Inc (EQ) - GuruFocus
Equillium COO Christine Zedelmayer sells $42,736 in stock By Investing.com - Investing.com Nigeria
Equillium (NASDAQ: EQ) Form 144: insider resale activity, 200,000-share sale noted - Stock Titan
Equillium Insider Sold Shares Worth $723,830, According to a Recent SEC Filing - marketscreener.com
Equillium (EQ) COO sells 14,584 shares after exercising stock options - Stock Titan
Equillium (NASDAQ: EQ) CSO Stephen Connelly sells 230,975 shares in open market - Stock Titan
[144] Equillium, Inc. SEC Filing - Stock Titan
Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory DiseaseSlideshow (NASDAQ:EQ) 2026-06-03 - Seeking Alpha
Equillium Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
EQ Reiterated by Roth Capital -- Price Target Maintained at $12 - GuruFocus
B. Riley Securities Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Equillium Inc (EQ) 財務データ
収益
当期純利益
現金流量
EPS
Equillium Inc (EQ) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Zedelmayer Christine | Sr. Vice President and COO |
Jun 05 '26 |
Option Exercise |
0.79 |
14,584 |
11,448 |
77,170 |
| Zedelmayer Christine | Sr. Vice President and COO |
Jun 05 '26 |
Sale |
2.93 |
14,584 |
42,737 |
62,586 |
| Connelly Stephen | President and CSO |
Jun 04 '26 |
Sale |
3.16 |
200,000 |
632,760 |
793,000 |
| Connelly Stephen | President and CSO |
Jun 05 '26 |
Sale |
2.94 |
30,975 |
91,070 |
762,025 |
2.64%
大文字化:
|
ボリューム (24 時間):